Literature DB >> 23111858

Chronic kidney disease—a challenge for all ages.

Ian H de Boer.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23111858     DOI： 10.1001/jama.2012.30761

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Contrast Free Duplex-Assisted EVAR in Patients with Chronic Renal Insufficiency.

Authors:  Attila G Krasznai; Tim A Sigterman; Lee H Bouwman
Journal:  Ann Vasc Dis       Date:  2014-12-25

Review 2.  Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review.

Authors:  Andrew S Levey; Cassandra Becker; Lesley A Inker
Journal:  JAMA       Date:  2015-02-24       Impact factor: 56.272

3.  A comparison between 2017 FAS and 2012 CKD-EPI equations: a multi-center validation study in Chinese adult population.

Authors:  Zhenzhu Yong; Fen Li; Xiaohua Pei; Xun Liu; Dan Song; Xiaoxuan Zhang; Weihong Zhao
Journal:  Int Urol Nephrol       Date:  2018-10-24       Impact factor: 2.370

4.  Semiautomated quantitative image analysis of glomerular immunohistochemistry markers desmin, vimentin, podocin, synaptopodin and WT-1 in acute and chronic rat kidney disease models.

Authors:  J Funk; V Ott; A Herrmann; W Rapp; S Raab; W Riboulet; A Vandjour; E Hainaut; A Benardeau; T Singer; B Jacobsen
Journal:  Histochem Cell Biol       Date:  2015-12-15       Impact factor: 4.304

5.  Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Authors:  Amanda Mocroft; Jens D Lundgren; Michael Ross; Matthew Law; Peter Reiss; Ole Kirk; Colette Smith; Deborah Wentworth; Jacqueline Neuhaus; Christoph A Fux; Olivier Moranne; Phillipe Morlat; Margaret A Johnson; Lene Ryom
Journal:  PLoS Med       Date:  2015-03-31       Impact factor: 11.069

6.  JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.

Authors:  Katherine R Tuttle; Frank C Brosius; Sharon G Adler; Matthias Kretzler; Ravindra L Mehta; James A Tumlin; Yoshiya Tanaka; Masakazu Haneda; Jiajun Liu; Maria E Silk; Tracy E Cardillo; Kevin L Duffin; Joseph V Haas; William L Macias; Fabio P Nunes; Jonathan M Janes
Journal:  Nephrol Dial Transplant       Date:  2018-11-01       Impact factor: 5.992
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.